UBT251 vs Dulaglutide

Head-to-head comparison of UBT251 (UBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist) and Dulaglutide (Recombinant GLP-1 receptor agonist Fc fusion protein) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyUBT251Dulaglutide
CategoryWeight ManagementWeight Management
Full NameUBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonistRecombinant GLP-1 receptor agonist Fc fusion protein
Molecular WeightN/A~63,000 Da
Half-LifeApproximately 1 weekAbout 5 days
Amino AcidsN/AN/A
Typical DoseInvestigational; no established human dose0.75-4.5 mg weekly
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count8700
Research StatusPre-clinicalApproved

UBT251 Benefits

  • weight reduction
  • improved satiety
  • enhanced energy expenditure
  • better insulin sensitivity

Dulaglutide Benefits

  • modest weight loss
  • lower A1c
  • weekly dosing convenience
  • cardiometabolic benefit

UBT251 Dosing

once-weekly subcutaneous injection|dose escalation in studies|maintenance after tolerability assessment

Dulaglutide Dosing

0.75-4.5 mg SC weekly|Increase based on response and tolerance|Administer on the same day each week

UBT251 Side Effects

  • nausea
  • diarrhea
  • fatigue

Dulaglutide Side Effects

  • nausea
  • diarrhea
  • injection-site reactions

Research Overview

UBT251

Published work supports strong anti-obesity activity in preclinical models, with translation into human studies still emerging. The compound remains investigational and is best characterized as an early multi-agonist program.

Dulaglutide

Dulaglutide has repeatedly shown small-to-moderate reductions in body weight alongside glycemic improvement in large diabetes trials. It is a useful comparator for GLP-1 receptor agonist effects on appetite and weight.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

UBT251 stacks with:

metforminorlistat

Dulaglutide stacks with:

metformindiet-and-exercise
glp1gipglucagontriagonistweight-managementGLP-1RAweekly-injectiontype-2-diabetesmodest-weight-loss